Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1 - PubMed (original) (raw)

Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1

G Englund et al. J Virol. 1995 May.

Abstract

Certain human immunodeficiency virus type 1 (HIV-1) isolates are able to productively infect nondividing cells of the monocyte/macrophage lineage. We have used a molecular genetic approach to construct two different HIV-1 integrase mutants that were studied in the context of an infectious, macrophage-tropic HIV-1 molecular clone. One mutant, HIV-1 delta D(35)E, containing a 37-residue deletion within the central, catalytic domain of integrase, was noninfectious in both peripheral blood mononuclear cells and monocyte-derived macrophages. The HIV-1 delta D(35)E mutant, however, exhibited defects in the assembly and/or release of progeny virions in transient transfection assays, as well as defects in entry and/or viral DNA synthesis during the early stages of monocyte-derived macrophage infection. The second mutant, HIV-1D116N/8, containing a single Asp-to-Asn substitution at the invariant Asp-116 residue of integrase, was also noninfectious in both peripheral blood mononuclear cells and monocyte-derived macrophages but, in contrast to HIV-1 delta D(35)E, was indistinguishable from wild-type virus in reverse transcriptase production. PCR analysis indicated that HIV-1D116N/8 entered monocyte-derived macrophages efficiently and reverse transcribed its RNA but was unable to complete its replication cycle because of a presumed block to integration. These data are consistent with the hypothesis that integration is an obligate step in productive HIV-1 infection of activated peripheral blood mononuclear cells and primary human macrophage cultures.

PubMed Disclaimer

Similar articles

• Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
  Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Engelman A, et al. J Virol. 1995 May;69(5):2729-36. doi: 10.1128/JVI.69.5.2729-2736.1995. J Virol. 1995. PMID: 7535863 Free PMC article.
• Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
  Masuda T, Planelles V, Krogstad P, Chen IS. Masuda T, et al. J Virol. 1995 Nov;69(11):6687-96. doi: 10.1128/JVI.69.11.6687-6696.1995. J Virol. 1995. PMID: 7474078 Free PMC article.
• Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.
  Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Kilareski EM, et al. Retrovirology. 2009 Dec 23;6:118. doi: 10.1186/1742-4690-6-118. Retrovirology. 2009. PMID: 20030845 Free PMC article. Review.
• Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.
  Le Douce V, Herbein G, Rohr O, Schwartz C. Le Douce V, et al. Retrovirology. 2010 Apr 9;7:32. doi: 10.1186/1742-4690-7-32. Retrovirology. 2010. PMID: 20380694 Free PMC article. Review.

Cited by

• Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB Sequestration.
  Campbell GR, Rawat P, Bruckman RS, Spector SA. Campbell GR, et al. PLoS Pathog. 2015 Jun 26;11(6):e1005018. doi: 10.1371/journal.ppat.1005018. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26115100 Free PMC article.
• Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction.
  Van Maele B, De Rijck J, De Clercq E, Debyser Z. Van Maele B, et al. J Virol. 2003 Apr;77(8):4685-94. doi: 10.1128/jvi.77.8.4685-4694.2003. J Virol. 2003. PMID: 12663775 Free PMC article.
• Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA.
  Vandegraaff N, Kumar R, Burrell CJ, Li P. Vandegraaff N, et al. J Virol. 2001 Nov;75(22):11253-60. doi: 10.1128/JVI.75.22.11253-11260.2001. J Virol. 2001. PMID: 11602768 Free PMC article.
• A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.
  O'Doherty U, Swiggard WJ, Jeyakumar D, McGain D, Malim MH. O'Doherty U, et al. J Virol. 2002 Nov;76(21):10942-50. doi: 10.1128/jvi.76.21.10942-10950.2002. J Virol. 2002. PMID: 12368337 Free PMC article.
• Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.
  Grobler JA, Stillmock K, Hu B, Witmer M, Felock P, Espeseth AS, Wolfe A, Egbertson M, Bourgeois M, Melamed J, Wai JS, Young S, Vacca J, Hazuda DJ. Grobler JA, et al. Proc Natl Acad Sci U S A. 2002 May 14;99(10):6661-6. doi: 10.1073/pnas.092056199. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997448 Free PMC article.

References

1. 1. Mol Cell Biol. 1986 Sep;6(9):3173-9 - PubMed
2. 1. J Virol. 1994 Apr;68(4):2503-12 - PubMed
3. 1. J Mol Biol. 1967 Jun 14;26(2):365-9 - PubMed
4. 1. J Virol. 1974 Sep;14(3):531-46 - PubMed
5. 1. Cell. 1977 Jun;11(2):307-19 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database